EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation

Maria Motrenikova iD, Krasimir Boyanov iD, Neli Bojinova, Anelia Bivolarska iD

Antioxidants · 2025-10-20 · 14 (10) · 1259

DOI: 10.3390/antiox14101259 ↗

At a glance

Übersichtsarbeit in Antioxidants, published online on 2025-10-20. Written by Maria Motrenikova and 3 co-authors. Institution: Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, Vasil Aprilov Str. 15A, 4002 Plovdiv, Bulgaria. Cited 20 times so far (Crossref); 103 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical University - Plovdiv, Medical University of Plovdiv.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This review aims to synthesize current evidence on the role of chronic stress and hypothalamic–pituitary–adrenal (HPA) axis dysregulation in the pathogenesis of chronic kidney disease (CKD). The focus is on the interplay between cortisol, oxidative stress, inflammation, and metabolic risk factors within the psycho-neuro-endocrine-immune (PNEI) system. CKD is a multifactorial disease characterized by oxidative stress, chronic low-grade inflammation, and neuroendocrine imbalance. These processes interact to accelerate renal injury and systemic complications. Pro-inflammatory mediators such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), together with oxidative stress markers including malondialdehyde (MDA), advanced oxidation protein products (AOPPs), and 8-hydroxy-2′-deoxyguanosine (8-OHdG), are strongly associated with disease progression. Altered cortisol dynamics—assessed in serum, saliva, and hair—further reflect chronic HPA activation and contribute to immune dysfunction, metabolic disturbances, and cardiovascular risk. By integrating experimental and clinical findings, this review highlights how stress-induced dysregulation of the PNEI system amplifies CKD progression. Understanding these interconnected mechanisms underscores the potential of combining oxidative, inflammatory, and neuroendocrine biomarkers for improved risk stratification and targeted therapeutic interventions.

Subjects

Author keywords

HPA dysregulationPNEI axisantioxidant defensechronic kidney diseasechronic stresscortisolinflammationoxidative stress

Authors and institutions

  • Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, Vasil Aprilov Str. 15A, 4002 Plovdiv, Bulgaria.
  • Dietary Nutrition Instructor, Medical College, Medical University of Plovdiv, Bratya Bukston Str. 120, 4004 Plovdiv, Bulgaria.

ORCID profiles: Maria Motrenikova, Krasimir Boyanov, Anelia Bivolarska

Funding

  • Medical University - Plovdiv
  • Medical University of Plovdiv

Cite

APA

Motrenikova, M., Boyanov, K., Bojinova, N., & Bivolarska, A. (2025). Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation. Antioxidants, 14(10), 1259. https://doi.org/10.3390/antiox14101259

Vancouver

Motrenikova M, Boyanov K, Bojinova N, Bivolarska A. Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation. Antioxidants. 2025;14(10):1259. doi:10.3390/antiox14101259

BibTeX
@article{Motrenikova2025,
  author = {Motrenikova, Maria and Boyanov, Krasimir and Bojinova, Neli and Bivolarska, Anelia},
  title = {Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1259},
  doi = {10.3390/antiox14101259}
}
Start for free →